|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
1 R01 AI148178-01 |
SCHWAB, SUSAN RUTH |
NIAID |
2020 |
|
Identification of complex cellular phenotypes and their interactions in MS lesions |
1 R21 AI149731-01 |
PITT, DAVID |
NIAID |
2020 |
|
Theilers virus RNA in exosomes secreted by infected microglia |
1 R21 AI151595-01 |
OLSON, JULIE K |
NIAID |
2020 |
|
Identifying quantitative trait loci that regulate enterovirus D68 pathogenesis using the Collaborative Cross |
1 R21 AI151996-01 |
RACANIELLO, VINCENT R |
NIAID |
2020 |
|
Induction of antiprotozoal secondary metabolites from endophytic fungi using epigenetic modifiers |
1 R21 AI154179-01 |
BAKER, BILL J |
NIAID |
2020 |
|
IFN responses and SARS-CoV-2 Receptor ACE2 Expression in the airway epithelium of young children with Down Syndrome |
3R01HL141237-02S1 |
NINO, GUSTAVO |
NIAID |
2020 |
|
Roles of DDX5 and its associated long non-coding RNAs in RORgt-mediated host immune system functions |
5R01AI121436-05 |
LITTMAN, DAN |
NIAID |
2020 |
|
Role of microglia in MHV-induced demyelination |
5R01NS036592-22 |
PERLMAN, STANLEY |
NIAID |
2020 |
|
In vivo production of a potassium channel inhibitor for immunomodulation |
5R21AI136876-02 |
BEETON, CHRISTINE |
NIAID |
2020 |
|
Probing antigen specificity and response of autoimmune B cells in Neuromyelitis Optica |
5R21AI144408-02 |
DEKOSKY, BRANDON JAMES |
NIAID |
2020 |